DD234265A5 - Verfahren zur herstellung von spiro-3-hetero-azolonen - Google Patents

Verfahren zur herstellung von spiro-3-hetero-azolonen Download PDF

Info

Publication number
DD234265A5
DD234265A5 DD27521983A DD27521983A DD234265A5 DD 234265 A5 DD234265 A5 DD 234265A5 DD 27521983 A DD27521983 A DD 27521983A DD 27521983 A DD27521983 A DD 27521983A DD 234265 A5 DD234265 A5 DD 234265A5
Authority
DD
German Democratic Republic
Prior art keywords
hydrogen
compounds
formula
acid
compound
Prior art date
Application number
DD27521983A
Other languages
German (de)
English (en)
Inventor
Christopher A Lipinski
Original Assignee
Pfizer Inc.,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc.,Us filed Critical Pfizer Inc.,Us
Publication of DD234265A5 publication Critical patent/DD234265A5/de

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD27521983A 1982-12-06 1983-12-06 Verfahren zur herstellung von spiro-3-hetero-azolonen DD234265A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44733782A 1982-12-06 1982-12-06

Publications (1)

Publication Number Publication Date
DD234265A5 true DD234265A5 (de) 1986-03-26

Family

ID=23775964

Family Applications (1)

Application Number Title Priority Date Filing Date
DD27521983A DD234265A5 (de) 1982-12-06 1983-12-06 Verfahren zur herstellung von spiro-3-hetero-azolonen

Country Status (7)

Country Link
JP (1) JPS59116274A (ko)
CS (1) CS244683B2 (ko)
DD (1) DD234265A5 (ko)
HU (1) HU193191B (ko)
IN (1) IN160449B (ko)
SU (1) SU1380610A3 (ko)
ZA (1) ZA839023B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203791A1 (en) * 1985-05-29 1986-12-03 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203791A1 (en) * 1985-05-29 1986-12-03 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors

Also Published As

Publication number Publication date
JPS59116274A (ja) 1984-07-05
CS244683B2 (en) 1986-08-14
IN160449B (ko) 1987-07-11
CS913083A2 (en) 1985-09-17
ZA839023B (en) 1985-07-31
JPH0251548B2 (ko) 1990-11-07
SU1380610A3 (ru) 1988-03-07
HU193191B (en) 1987-08-28

Similar Documents

Publication Publication Date Title
DE69013836T2 (de) Benzimidazolverbindungen und deren Anwendung.
AT390257B (de) Verfahren zur herstellung neuer imidazo(4,5-b)chinolin-derivate
US4436745A (en) Method of inhibiting aldose reductase activity
US4438272A (en) Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
CH650782A5 (de) Carbostyrilverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
DE3717291A1 (de) Imidazochinolinyletherderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE19510965A1 (de) Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
EP0183159A2 (de) 1-Heteroaryl-4-aryl-pyrazolin-5-one zur Verwendung als Arzneimittel
DD242230A5 (de) Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
DE3533331A1 (de) Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69101449T2 (de) 1,3-Dicarbonylverbindungen und ihre Verwendung.
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD265403A5 (de) Verfahren zum herstellen herzstimulierender chinolene
DE2730832A1 (de) Thieno-(2,3-c)- und -(3,2-c)pyridine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE10115408A1 (de) Benzofuran-Derivate
DD251972A5 (de) Verfahren zur herstellung von spiroimidazolidinen
DD219482A5 (de) Verfahren zur herstellung von spiro-3-heteroazolonen
DD234265A5 (de) Verfahren zur herstellung von spiro-3-hetero-azolonen
CH647777A5 (de) Substituierte pyrido-(1,2-a)-pyrimidine.
DE2359773C2 (ko)
EP0024560B1 (de) Neue 3-Amino-1-benzoxepin-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3889497T2 (de) 3,4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-e]-1,2-thiazine-4-carboxamid-1,1-dioxide.
CA1200247A (en) Method of inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluorofluoren and spiro-difluorofluoren compounds
US4540700A (en) Treatment of diabetic complications with certain spiro-imidazolidine-diones
DD254001A5 (de) Verfahren zur herstellung von heterocyclischen oxophtalazinylessigsaeuren

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee